Cargando…
Structural Biology and Protein Engineering of Thrombolytics
Myocardial infarction and ischemic stroke are the most frequent causes of death or disability worldwide. Due to their ability to dissolve blood clots, the thrombolytics are frequently used for their treatment. Improving the effectiveness of thrombolytics for clinical uses is of great interest. The k...
Autores principales: | Mican, Jan, Toul, Martin, Bednar, David, Damborsky, Jiri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637190/ https://www.ncbi.nlm.nih.gov/pubmed/31360331 http://dx.doi.org/10.1016/j.csbj.2019.06.023 |
Ejemplares similares
-
Development and Testing of Thrombolytics in Stroke
por: Nikitin, Dmitri, et al.
Publicado: (2021) -
Computer-aided engineering of staphylokinase toward enhanced affinity and selectivity for plasmin
por: Nikitin, Dmitri, et al.
Publicado: (2022) -
Computational Study of Protein-Ligand Unbinding for Enzyme Engineering
por: Marques, Sérgio M., et al.
Publicado: (2019) -
Engineering the protein dynamics of an ancestral luciferase
por: Schenkmayerova, Andrea, et al.
Publicado: (2021) -
Substrate inhibition by the blockage of product release and its control by tunnel engineering
por: Kokkonen, Piia, et al.
Publicado: (2021)